LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Molon, Cinzia"
  2. AU="Ivin, Masa"

Suchergebnis

Treffer 1 - 1 von insgesamt 1

Suchoptionen

Artikel ; Online: Economic and outcomes consequences of TachoSil®: a systematic review.

Colombo, Giorgio L / Bettoni, Daria / Di Matteo, Sergio / Grumi, Camilla / Molon, Cinzia / Spinelli, Daniela / Mauro, Gaetano / Tarozzo, Alessia / Bruno, Giacomo M

Vascular health and risk management

2014  Band 10, Seite(n) 569–575

Abstract: Background: TachoSil(®) is a medicated sponge coated with human fibrinogen and human thrombin. It is indicated as a support treatment in adult surgery to improve hemostasis, promote tissue sealing, and support sutures when standard surgical techniques ... ...

Abstract Background: TachoSil(®) is a medicated sponge coated with human fibrinogen and human thrombin. It is indicated as a support treatment in adult surgery to improve hemostasis, promote tissue sealing, and support sutures when standard surgical techniques are insufficient. This review systematically analyses the international scientific literature relating to the use of TachoSil in hemostasis and as a surgical sealant, from the point of view of its economic impact.
Methods: We carried out a systematic review of the PubMed literature up to November 2013. Based on the selection criteria, papers were grouped according to the following outcomes: reduction of time to hemostasis; decrease in length of hospital stay; and decrease in postoperative complications.
Results: Twenty-four scientific papers were screened, 13 (54%) of which were randomized controlled trials and included a total of 2,116 patients, 1,055 of whom were treated with TachoSil. In the clinical studies carried out in patients undergoing hepatic, cardiac, or renal surgery, the time to hemostasis obtained with TachoSil was lower (1-4 minutes) than the time measured with other techniques and hemostatic drugs, with statistically significant differences. Moreover, in 13 of 15 studies, TachoSil showed a statistically significant reduction in postoperative complications in comparison with the standard surgical procedure. The range of the observed decrease in the length of hospital stay for TachoSil patients was 2.01-3.58 days versus standard techniques, with a statistically significant difference in favor of TachoSil in eight of 15 studies.
Conclusion: This analysis shows that TachoSil has a role as a supportive treatment in surgery to improve hemostasis and promote tissue sealing when standard techniques are insufficient, with a consequent decrease in postoperative complications and hospital costs.
Mesh-Begriff(e) Blood Loss, Surgical/prevention & control ; Cost-Benefit Analysis ; Drug Combinations ; Drug Costs ; Fibrinogen/adverse effects ; Fibrinogen/economics ; Fibrinogen/therapeutic use ; Hemostatic Techniques/adverse effects ; Hemostatic Techniques/economics ; Hemostatics/economics ; Hemostatics/therapeutic use ; Hospital Costs ; Humans ; Length of Stay/economics ; Outcome and Process Assessment, Health Care/economics ; Postoperative Hemorrhage/economics ; Postoperative Hemorrhage/prevention & control ; Thrombin/adverse effects ; Thrombin/economics ; Thrombin/therapeutic use ; Time Factors ; Treatment Outcome
Chemische Substanzen Drug Combinations ; Hemostatics ; TachoSil ; Fibrinogen (9001-32-5) ; Thrombin (EC 3.4.21.5)
Sprache Englisch
Erscheinungsdatum 2014-09-10
Erscheinungsland New Zealand
Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review ; Systematic Review
ZDB-ID 2186568-1
ISSN 1178-2048 ; 1176-6344
ISSN (online) 1178-2048
ISSN 1176-6344
DOI 10.2147/VHRM.S63199
Signatur
Zs.A 6066: Hefte anzeigen Standort:
Je nach Verfügbarkeit (siehe Angabe bei Bestand)
bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular
ab Jg. 2022: Lesesaal (EG)
Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

Zusatzmaterialien

Kategorien

Zum Seitenanfang